A 52 Week Study to Evaluate the Effects of Losartan With or Without HCTZ on Plasma Glucose, Metabolic Parameters, Blood Pressure in Hypertensive Patients With Metabolic Syndrome (0954A-331)

Clinical trial NCT00546052 · COMPLETED

Trial details

NCT number: NCT00546052
Sponsor: Organon and Co
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypertension Metabolic Disorder

Start date: 2005-09-01
Primary completion: 2008-01-01
Enrollment: 1738

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.